Nodal marginal zone B-cell lymphoma

4 total trials MedDRA PT

Filter these 4 trials by phase, country, sponsor and more.

Open in Search →

Epcoritamab in Relapsed/Refractory Marginalzone Lymphoma - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (EPOS-1) Pending

2025-524879-23-00 4 "Marginal Zone Lymphoma"
A study to evaluate the efficacy and safety of JCAR017 in adult subjects with a type of cancer that affects B-cells, a type of white blood c … Recruitment ended

2024-510966-18-00 4 2024-06-03 "Relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma "
Copanlisib and Rituximab in Marginal Zone Lymphoma Patients - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (COUP-1) Recruitment ended

2022-500674-34-00 4 2019-11-04 "Marginal Zone Lymphoma"
Obinutuzumab in marginal zone lymphoma - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (OLYMP-1) Recruitment ended

2024-517476-38-00 4 2018-05-14 "Marginal Zone Lymphoma"

Showing 1–4 of 4 trials